News About: Pharm. Industry
82 generics approved in May
The Ministry of Food and Drug Safety (MFDS) said Wednesday that a total of 82 generics made by Korean drug makers had been granted approval for sale last month.
The drug authority confirmed that the substances (e.g...
Dr. Choi Ju-hyon named to head Sanofi Aventis Korea’s R&D operationsSanofi Aventis Korea said Wednesday it has appointed as its research development director, Choi Ju-yeon, a world-renowned expert in developing new drugs.
Choi will take char...
|
Hanmi to release generic Nexium in U.S. market shortly
Hanmi Pharmaceutical Co. on Tuesday announced that based on a confidential settlement agreement, a consent judgment has been entered by the United States District Court for the District of New Jersey with respect to t...
4 drug firms showing higher dependence of other licensing products
Korea’s four drug firms, such as Ilsung Pharm, Kwandong Pharm, Dongkook Pharm and Daewha Pharm, saw their dependence on other firms’ licensing products to gross sales jump in the first quarter of this year, data showe...
On-line drug shopping malls exposed to fiercer competition
Pharmsnet, Korea’s on-line drug shopping mall leader, will not be as stable as before with Hanmi Pharm and Daewoong Pharm have entered the electronic commerce market to grab a bigger piece of the pie.
Amid the fier...
Celltrion completes Phase III clinical trials for CT-6P
Celltrion on Tuesday said that it has completed Phase III trials for its biosimilar candidate CT-P6 to demonstrate he comparable bioequivalence, efficacy and safety of CT-P6 to the reference drug.
CT-P6 is intended...
Korean drugmakers’ R&D spending falls slightly in 1Q
Korea’s 53 listed pharmaceutical companies saw their combined research and development (R&D) spending drop by 7.4 percent to 185.3 billion won, down 0.2 percent points from 7.6 percent a year ago, an online pharmaceut...
Takeda Korea receives MFDS approval for Nesina for type 2 diabetes
Takeda Korea Monday announced that the Ministry of Food and Drug Safety (MFDS) has approved Nesina (alogliptin) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.
People with type 2 di...
Janssen Korea names two female executivesJanssen Korea said Monday that it appointed two females, Min Hyang-won and Lim Kyung-hwa, to executive posts.
Newly appointed director Min will lead the company’s regulatory ...
|
KPMA picks new communication directorThe Korea Pharmaceutical Manufacturers Association (KPMA) yesterday picked an ex-journalist Lee Jae-gook to work as its new communication director.
Lee was appointed to make ...
|
